Quick Answer
AEON Biopharma, Inc. reported Stockholders Equity of -$55.03 million for fiscal year 2025.
AEON Biopharma, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$55.03M | -92.6% |
| 2024 | -$28.57M | +81.3% |
| 2023 | -$153.04M | -191.6% |
| 2023 | $167.14M | +158.1% |
| 2022 | -$287.50M | -1598.2% |
| 2021 | -$16.93M | -79167.1% |
| 2020 | $21.4K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$19.87M | +38.1% | -25.4% |
| June 30, 2025 | -$15.85M | +43.3% | -40.0% |
| March 31, 2025 | -$11.32M | +94.3% | +60.4% |
| December 31, 2024 | -$28.57M | +81.3% | +11.0% |
| September 30, 2024 | -$32.09M | +73.6% | -14.8% |
| June 30, 2024 | -$27.95M | -143.8% | +85.9% |
| March 31, 2024 | -$198.38M | -2610.9% | -29.6% |
| December 31, 2023 | -$153.04M | — | -25.7% |
- AEON Biopharma, Inc. showed a decrease of -92.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, AEON Biopharma, Inc.’s stockholders equity has declined by 257091.4% (from $21.4 thousand to -$55.03 million).
- The most recent figure is from AEON Biopharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: